Lv11
40 积分 2021-09-24 加入
Evaluating the Cost-Effectiveness of Etranacogene Dezaparvovec Gene Therapy for Hemophilia B Treatment in the USA
1小时前
求助中
Assessment of Visual Function with Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa in the Randomized XIRIUS Phase 2/3 Study
2小时前
已完结
Pathology Findings and In-Life Correlates in the Nonclinical Development of Adeno-Associated Virus (AAV)-Based Retinal Gene Therapies
5小时前
已完结
Current Clinical Applications of AAV-mediated Gene Therapy
6小时前
已关闭
The Cost of Biotech Innovation: Exploring Research and Development Costs of Cell and Gene Therapies
21天前
已完结
Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia B
21天前
已完结
Changing trends in the development of AAV-based gene therapies: a meta-analysis of past and present therapies
24天前
已完结
Multiple gene therapy as a tool for regulating the expression of molecules involved in neovascular age-related macular degeneration
1个月前
已完结
Etranacogene dezaparvovec gene therapy for haemophilia B (HOPE-B): 24-month post-hoc efficacy and safety data from a single-arm, multicentre, phase 3 trial
10个月前
已完结
Adeno-Associated Viral Vector Integration: Implications for Long-Term Efficacy and Safety
10个月前
已完结
皖公网安备34019202002308
